Printer Friendly

AMEX OPENS OPTIONS TRADING ON IMMUNOGEN

 AMEX OPENS OPTIONS TRADING ON IMMUNOGEN
 NEW YORK, Feb. 19 /PRNewswire/ -- The American Stock Exchange today


opened put and call options on the over-the-counter stock of ImmunoGen, Inc. (options symbol: GEQ).
 Headquartered in Cambridge, Mass., ImmunoGen develops pharmaceuticals for the treatment of cancer.
 GEQ opened with strike prices of 17-1/2, 20 and 22-1/2, and position limits of 3,000 contracts. Initial expiration months are March, April, June, and September of 1992. Miceli, Van Caneghan and Co. is the specialist unit for the new options.
 The Amex trades a total of 268 stock options, including 79 options on over-the-counter stocks. In addition, options are traded on five broad market indexes -- the Major Market Index (XMI), XMI LEAPS(TM) (XLT), S&P MidCap 400 Index (MID), the Institutional Index (XII) and the Japan Index (JPN) -- as well as two industry-based indexes --the Oil Index (XOI) and the Computer Technology Index (XCI). CAPS -- capped options -- are traded on XMI and XII as well. The exchange also trades 27 LEAPS(TM) on leading stocks which have expirations up to almost three years.
 -0- 2/19/92
 /CONTACT: Shelly Wolfe of AMEX, 212-306-1641/ CO: ImmunoGen Inc. ST: Massachusetts IN: MTC SU: SH -- NY034 -- 0400 02/19/92 11:17 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 19, 1992
Words:207
Previous Article:ECC GROUP PLC ANNOUNCES CONSTRUCTION MATERIALS ACQUISITION IN DENVER
Next Article:SHERWIN-WILLIAMS RAISES QUARTERLY DIVIDEND TO $0.11 FROM $.105
Topics:


Related Articles
AMEX DEVELOPS BIOTECHNOLOGY INDEX; SEEKS SEC PERMISSION TO TRADE OPTIONS ON NEW INDEX
AMEX'S BIOTECHNOLOGY INDEX VALUE NOW AVAILABLE ON MARKET DATA MACHINES
AMEX REPLACES FOUR STOCKS IN ITS BIOTECHNOLOGY INDEX
AMEX'S PHARMACEUTICAL INDEX OPTIONS 'DRG' OFF TO STEADY START; OPEN INTEREST EXCEEDS 5,000 CONTRACTS
First Live On-Line Video of Wall Street Featured on New Amex Web Site
ImmunoGen, Inc. Receives Second Milestone Payment from SmithKline Beecham as Part of Colorectal Cancer Treatment Agreement.
ImmunoGen, Inc. Elects to Exercise $2.5 Million Put Option Under SmithKline Beecham Agreement.
ImmunoGen Options Antibody from Duke and Johns Hopkins Universities for Potential Development as Novel Cancer Therapeutic.
American Stock Exchange to Trade Options on Huaneng Power International, Inc. and Lipid Sciences, Inc.
Step Onto the New NYSE Amex Options Trading Floor.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters